REG - Urban&Civic Plc - Delisting and cancellation of trading
RNS Number : 5880MUrban&Civic plc22 January 2021NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
22 January 2021
URBAN&CIVIC plc
Delisting and cancellation of trading of Urban&Civic Shares
Further to the announcement made by Urban&Civic plc ("Urban&Civic") and by The Wellcome Trust Limited as trustee of the Wellcome Trust ("Wellcome") on 21 January 2021, Urban&Civic today announces that, following applications by Urban&Civic, the FCA has cancelled the listing of Urban&Civic Shares on the premium segment of the Official List of the FCA and the London Stock Exchange has cancelled the trading of Urban&Civic Shares on the London Stock Exchange's main market for listed securities, in each case with effect from 8.00 a.m. today, 22 January 2021. Full details of the Acquisition and the Offer are set out in the scheme document published by Urban&Civic on 20 November 2020 (the "Scheme Document").
Capitalised terms used but not otherwise defined in this announcement shall have the meaning given to them in the Scheme Document, a copy of which is available on the Urban&Civic website at https://www.urbanandcivic.com/investors. All references to time are to London times.
Enquiries:
Urban&Civic
Nigel HugillDavid Wood
+44 (0)20 7509 5555
J.P. Morgan Cazenove (Sole financial adviser to Urban&Civic)
Bronson AlberyCelia Murray
Tara Morrison
Jonty Edwards
+44(0)20 7742 4000
FTI Consulting (Public Relations Adviser to Urban&Civic)
Giles BarrieDido Laurimore
Email:
+44 (0)7798 926 814
+44 (0)7801 654 424
urban&civic@fticonsulting.com
UBS (Financial Adviser to Wellcome)
Ian HartAadhar Patel
+44 (0)20 7567 8000
Brunswick (Public Relations Adviser to Wellcome)
Jonathan GlassNina Coad
Emily Trapnell
+44 (0)20 7404 5959
CMS Cameron McKenna Nabarro Olswang LLP is retained as legal adviser to Urban&Civic. Slaughter and May is retained as legal adviser to Wellcome.
IMPORTANT NOTICES
J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), and which is authorised in the United Kingdom by the PRA and regulated by the PRA and the FCA, is acting as financial adviser exclusively for Urban&Civic and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Urban&Civic for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.
UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS is acting as financial adviser to Wellcome and no one else in connection with the Offer. In connection with such matters, UBS, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in relation to the Acquisition, the contents of this announcement or any other matter referred to herein.
This announcement and the documents required to be published pursuant to Rule 26.1 of the City Code will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Wellcome's website at https://wellcome.org/about-us/investments and Urban&Civic's website at https://www.urbanandcivic.com/investors promptly and in any event by no later than 12 noon (London time) on the Business Day following the date of this announcement. The content of the websites referred to in this announcement are not incorporated into and do not form part of this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDMSCSEWSWEEFSELF
Recent news on FTI Consulting
See all newsRCS - Draslovka a.s. - Draslovka partnership with Natron Energy
AnnouncementREG - Brit Group Holdings - Annual Financial Report
AnnouncementREG - Redx Pharma Limited - Phase 1 Data on RXC008 Presented at ECCO
AnnouncementRCS - Redx Pharma plc - Preclinical Data on RXC008 Presented at UEG Week
AnnouncementREG - Brit Limited - Half-year Report
Announcement